Probiotic Supplementation in Breastfed Newborn Infants
Status:
Withdrawn
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the dose of a probiotic supplement
(Bifidobacterium longum subsp. infantis) required to achieve predominant gut colonization in
healthy newborn, breastfed infants. The study will also examine whether supplementation with
this probiotic can reduce the chance of developing eczema and food allergies in enrolled
infants.
Phase:
Phase 1
Details
Lead Sponsor:
Emanual Maverakis, MD University of California, Davis